Skip to content

Latest Publication: Read our teams’ latest paper in Antibiotics, showing reduced nephrotoxicity of a novel formulation of polymyxin B compared to the clinical formulation using a validated primary human proximal tubule cell model.

Emile Shaffu

Sales Director

Emile brings a wealth of commercial and technical expertise spanning molecular biology and cutting-edge genomic technologies, with a proven track-record in developing successful sales strategies and driving the adoption of innovative scientific solutions. Most recently as UK Regional Business Manager at Californian-based Bionano Genomics, he spearheaded the successful introduction of the Company’s novel optical genome mapping technique to the UK market, working closely to employ the technology across industry, the NHS, and academia. During his five-year tenure at Horizon Discovery (now Revvity), Emile held various positions responsible for expanding and fortifying customer networks for its portfolio of drug discovery CRISPR/RNAi products and screening services in the UK, Europe, and the US. He also gained experience within the Nordic market through his role at epigenetics company, Diagenode. Emile holds a Master’s degree in Business Studies from Aston University and a BSc in Biomedical Sciences from Sheffield Hallam University.

Get our latest updates straight to your inbox